Enhanced Pathogenicity of Diabetogenic T Cells Escaping a Non-MHC Gene-Controlled Near Death Experience

Journal of Immunology - United States
doi 10.4049/jimmunol.173.6.3791
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The American Association of Immunologists

Related search

The Near-Death Experience

British Journal of Psychiatry
MedicinePsychiatryMental Health
1989English

Escaping Death: Mitochondrial Redox Homeostasis in Cancer Cells

Frontiers in Oncology
Cancer ResearchOncology
2017English

Congenic Mapping and Functional Analysis of a Second Component of the MHC-linked Diabetogenic Gene (Idd16)

International Journal of Diabetes and Metabolism
2000English

Near Death Experience: Neuroscience Perspective

Croatian Medical Journal
Medicine
2015English

Neuropsychiatric Aspects of Near-Death Experience

Annals of International medical and Dental Research
2018English

Table 3: Participants Claiming a Near-Death Experience, Analyzed According to Greyson Near-Death Experience Scale Scores.

English

Over Easy: A Cultural Anthropologist's Near-Death Experience.

Journal of Near-Death Studies
1982English

IFN-γ Receptor Deficiency Prevents Diabetes Induction by Diabetogenic CD4+T Cells but Not CD8+T Cells

European Journal of Immunology
AllergyImmunology
2012English

Intestinal Type 1 Regulatory T Cells Migrate to Periphery to Suppress Diabetogenic T Cells and Prevent Diabetes Development

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy